The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan® at clinical and supraclinical doses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 6, 2008, Pages 571-579

  Whittem, T ^a,c   Pasloske, K S ^a   Heit, M C ^b   Ranasinghe, M G ^a  

^a Jurox Pty Ltd   (Australia)

^b Provident Preclinical Inc   (United States)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALFAXALONE; ALFAXAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RESPONSE; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANESTHESIA; ANESTHETICS; ANIMALS; AREA UNDER CURVE; BLOOD PRESSURE; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MALE; MODELS, THEORETICAL; PREGNANEDIONES;

FELIS CATUS;

EID: 55949094025     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00998.x     Document Type: Article

References (22)

1. Anonymous (1998) OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. Number 1. OECD Principles on Good Laboratory Practice (as revised in 1997) No. ENV/MC/CHEM(98)17. OECD, Paris.
2. Brewster, M.E., Estes, K.S. Bodor, N. (1989) Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. Journal of Parenteral Science and Technology, 43, 262 265.
3. Child, K.J., Gibson, W., Harnby, G. Hart, J.W. (1972) Metabolism and excretion of Althesin (CT 1341) in the rat. Postgraduate Medical Journal, 48 (Suppl. 2 37 43.
4. Clarke, R.S., Dundee, J., Garrett, F.T., McArdle, G.K. Sutton, J.A. (1975) Adverse reactions to intravenous anaesthetics. British Journal of Anaesthesia, 47, 575 585.
5. Dayton, P.G., Cucinell, S.A., Weiss, M. Perel, J.M. (1967) Dose-dependence of drug plasma level decline in dogs. Journal of Pharmacology and Experimental Therapeutics, 158, 305 316.
6. Dodman, N.H. (1980) Complications of Saffan anaesthesia in cats. Veterinary Record, 107, 481 483.
7. Dutta, S. Ebling, W.F. (1997) Emulsion formulation reduces propofol's dose requirements and enhances safety. Anesthesiology, 87, 1394 1405.
8. Ennis, M. Lorenz, W. (1985) Modulation of histamine release by fatty acids. A new in vitro model investigating adverse drug reactions in various species. Annales Francaises d'Anesthesie et de Reanimation, 4, 124 128.
9. Ferre, P.J., Pasloske, K., Whittem, T., Ranasinghe, M.G., Li, Q. Lefebvre, H.P. (2006) Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Veterinary Anaesthesia and Analgesia, 33, 229 236.
10. Fisher, M.M. (1975) Severe histamine mediated reactions to intravenous drugs used in anaesthesia. Anaesthesia and Intensive Care, 3, 180 197.
11. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker Inc, New York.
12. ®) in cats. Veterinary Anaesthesia and Analgesia, in press.
13. Nicholas, T.E., Jones, M.E., Johnson, D.W. Phillipou, G. (1981) Metabolism of the steroid anaesthetic alphaxalone by the isolated perfused rat lung. Journal of Steroid Biochemistry, 14, 45 51.
14. Paul, M., Dueck, M., Kampe, S., Fruendt, H. Kasper, S.M. (2003) Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil. Anaesthesia, 58, 1056 1062.
15. Piperno, E., Ellis, D.J., Getty, S.M. Brody, T.M. (1968) Plasma and urine levels of phenylbutazone in the horse. Journal of the American Veterinary Medical Association, 153, 195 198.
16. Powers, J. (1990) Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics, 13, 113 120.
17. Runkel, R., Forchielli, E., Sevelius, H., Chaplin, M. Segre, E. (1974) Nonlinear plasma level response to high doses of naproxen. Clinical Pharmacology and Therapeutics, 15, 261 266.
18. Sear, J.W. McGivan, J.D. (1981) Metabolism of alphaxalone in the rat: evidence for the limitation of the anaesthetic effect by the rate of degradation through the hepatic mixed function oxygenase system. British Journal of Anaesthesia, 53, 417 424.
19. Toutain, P.L. Bousquet-Melou, A. (2004) Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics, 27, 415 425.
20. Veng-Pedersen, P. (1989) Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part 1). Clinical Pharmacokinetics, 17, 345 366.
21. Whittem, T. (1993) The population distribution of some pharmacokinetic parameters is not normal. A prediction based on computer modelling (abstract). Proc Australasian Soc Clin Exper Pharm & Toxicol (New Zealand Section) Annual Meeting. New Zealand Medical Journal, 106, 37.
22. Zoran, D.L., Riedesel, D.H. Dyer, D.C. (1993) Pharmacokinetics of propofol in mixed-breed dogs and greyhounds. American Journal of Veterinary Research, 54, 755 760.